BioSyent, Inc. (RX.V)
15.74
+0.24
(+1.55%)
CAD |
TSXV |
Aug 25, 10:36
BioSyent Market Cap : 178.50M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 175.77M |
| August 21, 2026 | 178.04M |
| August 20, 2026 | 167.27M |
| August 19, 2026 | 167.27M |
| August 18, 2026 | 165.57M |
| August 17, 2026 | 169.56M |
| August 14, 2026 | 177.11M |
| August 13, 2026 | 174.32M |
| August 12, 2026 | 171.88M |
| August 11, 2026 | 174.21M |
| August 10, 2026 | 174.21M |
| August 07, 2026 | 174.21M |
| August 06, 2026 | 179.90M |
| August 05, 2026 | 180.01M |
| August 04, 2026 | 170.14M |
| July 31, 2026 | 171.30M |
| July 30, 2026 | 170.26M |
| July 29, 2026 | 170.26M |
| July 28, 2026 | 171.30M |
| July 27, 2026 | 171.19M |
| July 24, 2026 | 171.19M |
| July 23, 2026 | 170.61M |
| July 21, 2026 | 170.72M |
| July 20, 2026 | 168.40M |
| July 17, 2026 | 168.40M |
| Date | Value |
|---|---|
| July 16, 2026 | 168.40M |
| July 15, 2026 | 169.56M |
| July 14, 2026 | 169.56M |
| July 13, 2026 | 169.44M |
| July 10, 2026 | 169.56M |
| July 09, 2026 | 170.95M |
| July 08, 2026 | 170.02M |
| July 07, 2026 | 167.47M |
| July 06, 2026 | 169.21M |
| July 03, 2026 | 168.40M |
| July 02, 2026 | 167.70M |
| June 30, 2026 | 168.40M |
| June 29, 2026 | 170.61M |
| June 26, 2026 | 163.17M |
| June 25, 2026 | 161.78M |
| June 24, 2026 | 162.59M |
| June 23, 2026 | 163.06M |
| June 22, 2026 | 162.59M |
| June 19, 2026 | 162.01M |
| June 18, 2026 | 162.01M |
| June 17, 2026 | 160.97M |
| June 16, 2026 | 162.59M |
| June 15, 2026 | 162.01M |
| June 12, 2026 | 161.31M |
| June 11, 2026 | 162.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 118.20M |
| Bausch Health Cos., Inc. | 3.343B |
| Cipher Pharmaceuticals, Inc. | 359.37M |
| Revive Therapeutics Ltd. | 10.89M |
| Knight Therapeutics, Inc. | 964.56M |
Market Cap Related Metrics
| PE Ratio | 18.36 |
| PS Ratio | 3.251 |
| PEG Ratio | 0.9256 |
| Price to Book Value | 3.894 |
| Price to Free Cash Flow | 15.56 |
| Price | 15.74 |
| Earnings Yield | 5.45% |
| PEGY Ratio | 0.8664 |
| Operating PE Ratio | 14.03 |
| Normalized PE Ratio | 18.36 |